Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 5

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
The purpose of this study was to evaluate the effect of a combined treatment with carprofen and enalapril on ductus construction in the medical treatment of Golden retriever dogs with PDA which are unable to undergo surgical treatment and have delayed diagnosis. PDA was diagnosed by using Doppler, echocardiography, electrocardiography, X-ray, and blood analysis in 5 golden retrievers. Carprofen (2 mg/kg) and enalapril (0.5 mg/kg) were administered daily for 12 months and the dogs were controlled at 3 monthly intervals. Ductal construction was detected as 11% (p = ns) at the 3rd month, 24% (p < 0.05) at the 6th month, and 31% (p < 0.01) at the 9th month and 38% (p < 0.001) at the 1st year. An increase in the diameter of the main pulmonary artery was revealed after the 9th month (p < 0.05). No significant alteration was determined in the diameter of aorta, fractional shortening (FS %) and ejection fractioning (EF %) during the treatment. The results of the study indicated that the effect of a combined treatment of carprofen and enalapril is revealed after a long time period. Although a statistically significant decrease occurred in the diameter of the ductus, no complete closure in the ductus occurred. It was also detected that the severity of clinical signs in the dogs with PDA type-2, which had rendered them unacceptable for operation, was decreased by this medication.
The effects of the angiotensin converting enzyme inhibitors benazepril (B), enalapril (E), and ramipril (R) on the function, geometry, and dimensions of the left ventricle (LV) in the dogs with naturally acquired severe mitral regurgitation (MR) were evaluated by echocardiography. Thirty-two dogs, aged 8-16 years and weighing 10-12 kg, with fractional shortening (FS) >50% were included into the study. Benazepril (0.5mg/kg/d), enalapril (0.5mg/kg/d), and ramipril (0.5mg/kg/d) were administered orally to B, E, and R groups, respectively. Furosemide (2mg/kg/d) was administered orally for conventional heart failure therapy. Physical, radiographic, electrocardiographic, and echocardiographic examinations were performed before treatment and on day 7 after the treatment. A decrease in the left ventricle end diastolic diameter (LVEDd) in groups E and R and in end diastolic volume (EDV) in group E was considerable during the subacute period (P<0.05). The stroke volume (SV) significantly decreased in groups E and R (P<0.01), whereas group B dogs had a mild decrease (P<0.05). FS and ejection fraction (EF) that were higher before treatment decreased significantly in all groups after the treatment (P<0.001). Differences in SV, FS, and EF were not statistically significant between groups. It was detected that LV was remodelled as a result of the effects of enalapril and ramipril on LVEDd and also EDV was decreased by enalapril. Furthermore, it was observed that these ACE inhibitors were effective on geometry, dimensions, and functions on LV of the dogs with severe MR, and enalapril was found to be the most effective agent, followed by ramipril and benazepril.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.